Fund Information / Factsheet • Jul 22, 2024
Fund Information / Factsheet
Open in ViewerOpens in native device viewer
Performance
Share price
Benchmark
NAV


From July 2022, the benchmark changed from the EMIX Smaller European Companies ex UK Index to the MSCI Europe ex UK Small Cap Index.

| Relative NAV (Total return) |
4.2 | 1.9 | 2.8 | 36.0 | 72.4 | |
|---|---|---|---|---|---|---|
| Discrete year performance (%) |
Share price (total return) |
NAV (total return) |
||||
| 30/6/2023 to 30/6/2024 |
19.5 | 12.0 | ||||
| 30/6/2022 to 30/6/2023 |
13.6 | 16.4 | ||||
| 30/6/2021 to 30/6/2022 |
-23.1 | -21.1 | ||||
| 30/6/2020 to 30/6/2021 |
79.5 | 63.5 | ||||
| 30/6/2019 to 30/6/2020 |
-2.5 | 2.9 | ||||
| n/a | n/a | n/a |
over (%) 6m 1y 3y 5y 10y
All performance, cumulative growth and annual growth data is sourced from Morningstar.
Source: at 30/06/24. © 2024 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not predict future returns.
Commentary at a glance
Microtec, Resurs and Nordnet. Detractors included Stabilus, Quadient, Mersen and Cint Group, as well as not holding Zealand Pharma.
Despite the volatility caused by France's election, our outlook remains positive on European smaller companies. We expect the European economy to improve in the second half of the year.
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.
The Company seeks capital growth by investing in smaller and medium sized companies which are quoted, domiciled, listed or have operations in Europe (excluding the UK).
Providing unique access to Europe's growing small- and medium-sized companies with the sole aim of increasing shareholder capital.
| NAV (cum income) | 200.9p | |||
|---|---|---|---|---|
| NAV (ex income) | 196.9p | |||
| Share price | 178.4p | |||
| Discount(-)/premium(+) | -11.2% | |||
| Yield | 2.6% | |||
| Net gearing | 11% | |||
| Net cash | - | |||
| Total assets Net assets |
£889m £798m |
|||
| Market capitalisation | £709m | |||
| Total voting rights | 397,287,598 | |||
| Total number of holdings 129 |
||||
| Ongoing charges (year end 30 Jun 2023) |
0.65% | |||
| Benchmark | MSCI Europe ex UK Small Cap Index |
|||
| Overall Morningstar RatingTM As of 30/06/2024 |
||||
| Source: BNP Paribas for holdings information and Morningstar for all other data. Differences in calculation may occur due to the methodology used. |
||||
Please note that the total voting rights in the Company do not include shares held in Treasury.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
How to invest Go to www.janushenderson.com/howtoinvest Find out more Go to www.europeansmallercompaniestrust.com
AIC sector AIC European Smaller
Key information Stock code ESCT
Marketing Communication
| Top 10 holdings | (%) |
|---|---|
| Van Lanschot Kempen | 3.1 |
| TKH Group | 3.0 |
| SUESS MicroTec | 2.0 |
| KSB | 2.0 |
| IG Group | 1.7 |
| Stroeer | 1.7 |
| Fugro | 1.6 |
| DFDS | 1.6 |
| Criteo | 1.6 |
| u-blox | 1.5 |

The above geographical breakdown may not add up
to 100% as this only shows the top 10.

The above sector breakdown may not add up to 100% due to rounding.
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.


10 year total return of £1,000
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
| Companies | ||||
|---|---|---|---|---|
| Benchmark | MSCI Europe ex UK Small Cap Index |
|||
| Company type | Conventional (Ords) | |||
| Launch date | 1990 | |||
| Financial year | 30-Jun | |||
| Dividend payment | April, November | |||
| Management fee | 0.55% pa on first £800m of net assets and 0.45% pa in excess thereof. |
|||
| Performance fee | Yes | |||
| (See Annual Report & Key Information Document for more information) | ||||
| Regional focus | Europe | |||
| Fund manager appointment |
Ollie Beckett 2011 Rory Stokes 2014 Julia Scheufler 2024 |



How to invest Go to www.janushenderson.com/howtoinvest Customer services 0800 832 832
European smaller company equities were down in June, returning -4.2%.
The risk-off investor sentiment was driven by political uncertainty surrounding the upcoming French election after President Macron called a snap election for the lower house during the month. This decision came after he was defeated by Marine Le Pen's far-right National Rally party in the European parliamentary election held in early June.
Given the risk-off sentiment in the market, investors moved away from European small-caps, which tend to be more cyclical in nature (sensitive to moves in the wider economy), and towards more defensive companies.
Alzchem (German chemicals) was a top positive contributor due to the profitability of its creatine and nitroguanidine production businesses. Creatine is a compound most associated with bodybuilders, who take it as a supplement to enhance muscle growth. However, its benefits are widespread. It can be used to prevent sarcopenia (muscle loss) in older adults and it is also being used by Ozempic patients to maintain muscle mass. Alzchem is the only non-Chinese producer of creatine, and its product sells at a premium. A further driver is the company's production of nitroguanidine, which is used in explosives, with the chemical being a key ingredient in creating NATO-compliant munitions.
SUESS Microtec (German semiconductors) was one of the fund's top positive contributors, as it benefited from increased orders off the back of the continued artificial intelligence (AI) boom. We are waiting to see how the company expands its capacity to meet the high demand. The cyclical recovery in the information technology sector, with the market more optimistic about prior supply-chain and destocking issues, also helped boost its share price.
Another positive contributor to fund performance was Resurs (Swedish financial services), as the company benefited from a bid from a private equity firm at a 38% premium. We think this offer was a reflection of the continued financial capacity of private equity firms, with pension funds providing them with a steady source of capital. Listed companies are currently trading at a discount to unlisted companies, so we expect to see further bids across the fund's holdings.
Shares in Nordnet (Swedish trading platform) benefited from the market volatility over the month.
Stabilus (automotive supplier) detracted due to a deterioration in demand for its products. The Germanylisted company is known for its 'Powerise' product, which enables the automatic opening and closing of car boots. Car production numbers were down globally, and this negatively affected the company. Stabilus also missed its guidance and issued a profit warning. Additionally, the company's recent acquisition of Destaco has left it with a reasonable degree of leverage, leaving some concerned about a potential equity raise. For now, we continue to hold its shares.
The French election did cause trouble for our French holdings during the month. The main concern among investors is fiscal discipline if either the far-right or far-left gets a majority. Quadient and Mersen were both affected by these fears.
Cint Group also detracted in June due to weakness in market research companies after YouGov issued a profit warning.
A further detractor from relative fund performance was not holding Zealand Pharma, as the company's share price rose sharply after a trial showed its new weight-loss drug was successful in helping patients lose weight.
We added a position in Exosens (French manufacturer), which provides light amplification for night-vision goggles. We believe there is a need for the business due to the escalation of geopolitical conflicts. Exosens dominates the market outside the US, as US suppliers are not allowed to export their products in this category.
We also opened a small position in Envipco (Norwegian manufacturer of reverse vending machines) as there is the expectation of it moving into new geographical markets, such as Scotland. It was also trading at an attractive valuation and trading at a discount to its major competitor.
We sold Grenergy Renovables (Spanish energy) after concerning behaviour from a governance perspective put us off the stock.
We also sold Antin Infrastructure (private equity) as the company struggled to raise assets. We were hopeful that Antin would take part in a consolidation in the market. However, after it didn't, we decided to exit the position.
Factsheet - at 30 June 2024 Marketing Communication
We believe the volatility caused by the French election is temporary and does not diminish the prospects of European small-cap companies, as improving macroeconomic factors should outweigh any political uncertainty caused by the election and a new French government. We are positive about the scope for European small-caps compared with their large-cap counterparts and other opportunities in the US and the rest of the world.
In terms of the macroeconomic picture, we are hopeful about future rate cuts from the European Central Bank (ECB) and believe the European economy will improve during the second half of the year.
From a medium-term perspective, the combination of what we see as attractive valuations and improving earnings places European small-cap stocks in a favourable position in our view. We believe our balanced/ blended investment style is well suited to this market environment.
Marketing Communication

The amount by which the price per share of an investment company is either lower (at a discount) or higher (at a premium) than the net asset value per share (cum income), expressed as a percentage of the net asset value per share.
The effect of borrowing money for investment purposes (financial gearing). The amount a company can "gear" is the amount it can borrow in order to invest. Gearing is used in the expectation that the returns on the investments bought will exceed the costs of the borrowings that funded the purchase. This Company can also use synthetic gearing through derivatives and foreign exchange hedging and/or other non-fully funded instruments or techniques.
The Company's leverage is the sum of financial gearing and synthetic gearing. Details of the Company's leverage limits can be found in both the Key Information Document and Annual Report. Where a company utilises leverage, the profits and losses incurred by the company can be greater than those of a company that does not use leverage.
Share price multiplied by the number of shares in issue, excluding treasury shares, at month end. Shares typically priced mid-market at month-end closing.
The total value of a Company's assets less its liabilities.
The value of investments and cash, including current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The value of investments and cash, excluding current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The theoretical total return on shareholders' funds per share reflecting the change in Net Asset Value (NAV) assuming that dividends paid to shareholders were reinvested at NAV at the time the shares were quoted ex-dividend. A way of measuring investment management performance of investment trusts which is not affected by movements in discounts/premiums.
Total assets minus any liabilities such as bank loans or creditors.
A company's net exposure to cash/cash equivalents expressed as a percentage of shareholders' funds, after any offset against its gearing. This is only shown for companies that have gearing in place.
A company's total assets (less cash/cash equivalents) divided by shareholders' funds expressed as a percentage.
The total expenses for the financial year (excluding performance fee), divided by the average daily net assets, multiplied by 100.
The key measure used to assess risk is volatility of returns, using historic net asset value (NAV) performance of the Company over 1 and 3 years. In this instance volatility measures how much a company's NAV fluctuates over time in relation to the UK Equity market. The higher a volatility figure, the more the NAV has fluctuated (both up and down) over time. Please note that risk categorisations are indicative and based principally on historic data and should not be solely relied upon when making investment decisions.
Closing mid-market share price at month end.
The theoretical total return to the investor assuming that all dividends received were reinvested in the shares of the company at the time the shares were quoted ex-dividend. Transaction costs are not taken into account.
Cum Income NAV multiplied by the number of shares, plus prior charges at fair value.
Calculated by dividing the current financial year's dividends per share (this will include prospective dividends) by the current price per share, then multiplying by 100 to arrive at a percentage figure.
For a full list of terms please visit: https://www.janushenderson.com/engb/investor/glossary/
Factsheet - at 30 June 2024 Marketing Communication

Overall Morningstar Rating™ is a measure of a fund's risk-adjusted return, relative to similar funds. Fund share classes are rated from 1 to 5 stars, with the best performers receiving 5 stars and the worst performers receiving a single star.
Overall Morningstar Rating™ is shown for an investment company achieving a rating of 4 or 5.
Ratings should not be taken as a recommendation. For more detailed information about Morningstar Ratings, including its methodology, please go to https://shareholders.morningstar.com/investor-relations/governance/Compliance--Disclosure/default.aspx.
Not for onward distribution. Before investing in an investment trust referred to in this document, you should satisfy yourself as to its suitability and the risks involved, you may wish to consult a financial adviser. This is a marketing communication. Please refer to the AIFMD Disclosure document and Annual Report of the AIF before making any final investment decisions. Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested. Tax assumptions and reliefs depend upon an investor's particular circumstances and may change if those circumstances or the law change. Nothing in this document is intended to or should be construed as advice. This document is not a recommendation to sell or purchase any investment. It does not form part of any contract for the sale or purchase of any investment. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 78, Avenue de la Liberté, L-1930 Luxembourg, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).
Janus Henderson is a trademark of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.